Medical device company Amedica said it’s planning to put up nearly 3.2 million shares at $10 to $12 apiece in an initial public offering in the U.S.
Salt Lake City-based Amedica, which makes silicon nitride-based biomaterials for medical devices, said it plans to trade under the AMDA symbol on the NASDAQ exchange.
At the midpoint of the proposed offering range, Amedica would have an initial market capitalization of $143 million.
Amedica’s products are aimed at the orthopedic and spinal markets. The company makes interbody devices used in spinal fusion procedures; their semi-radiolucent silicon nitride material is designed to promote bone growth and help prevent infection.